EISAI LIMITED

๐Ÿ‡ฎ๐Ÿ‡ชIreland
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2007-07-23
Last Posted Date
2016-01-21
Lead Sponsor
Eisai Limited
Target Recruit Count
328
Registration Number
NCT00505622
Locations
๐Ÿ‡ซ๐Ÿ‡ท

Centre d'Investigation Clinique, Hospital Purpan, Toulouse, Toulouse Cedex, France

A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours

Phase 1
Suspended
Conditions
Interventions
First Posted Date
2007-04-13
Last Posted Date
2009-03-24
Lead Sponsor
Eisai Limited
Target Recruit Count
40
Registration Number
NCT00459823
Locations
๐Ÿ‡ช๐Ÿ‡ธ

Medical Oncology Service. Vall d'Hebron University Hospital, Barcelona, Spain

๐Ÿ‡ณ๐Ÿ‡ฑ

Department of Medical Oncology, Erasmus University Medical Centre, Rotterdam, Netherlands

Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2006-08-04
Last Posted Date
2014-07-11
Lead Sponsor
Eisai Limited
Target Recruit Count
723
Registration Number
NCT00360308
Locations
๐Ÿ‡ซ๐Ÿ‡ท

Pavillon Riser- Hopital Purpan, Toulouse Cedex, France

The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Phase 3
Completed
Conditions
First Posted Date
2006-02-06
Last Posted Date
2015-11-03
Lead Sponsor
Eisai Limited
Target Recruit Count
702
Registration Number
NCT00286897
Locations
๐Ÿ‡ง๐Ÿ‡ช

C.H.U.de Charleroi, Charleroi, Belgium

๐Ÿ‡ง๐Ÿ‡ช

Hopital St-Pierre, Ottignies, Belgium

๐Ÿ‡จ๐Ÿ‡ฟ

Fakultni nemocnice Kralovske Vinohrady, Praha 10, Czech Republic

and more 102 locations

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

First Posted Date
2006-01-23
Last Posted Date
2013-04-25
Lead Sponsor
Eisai Limited
Target Recruit Count
48
Registration Number
NCT00280384

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

Phase 4
Completed
Conditions
First Posted Date
2005-09-22
Last Posted Date
2016-01-08
Lead Sponsor
Eisai Limited
Target Recruit Count
1000
Registration Number
NCT00215592
Locations
๐Ÿ‡ฆ๐Ÿ‡น

Universitatsklinikum fur Neurologie, Innsbruck, Austria

๐Ÿ‡ฉ๐Ÿ‡ฐ

Danish Epilepsy Center, Dianalund, Denmark

๐Ÿ‡ฉ๐Ÿ‡ฐ

The Epilepsy Clinic, Glostrup, Denmark

and more 30 locations

Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)

Phase 4
Completed
Conditions
First Posted Date
2005-09-14
Last Posted Date
2010-01-29
Lead Sponsor
Eisai Limited
Registration Number
NCT00165607

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

Phase 3
Completed
Conditions
First Posted Date
2005-09-14
Last Posted Date
2013-05-10
Lead Sponsor
Eisai Limited
Registration Number
NCT00165815
Locations
๐Ÿ‡ฎ๐Ÿ‡ช

Belfast City Hospital, Belfast, Ireland

๐Ÿ‡ฎ๐Ÿ‡ช

Unit 20 Black Poo Technology Centerl, Blackpool, Ireland

๐Ÿ‡ฉ๐Ÿ‡ช

Parkinson Klinik Wolfach, Wolfach, Germany

and more 1 locations

An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin

Phase 2
Completed
Conditions
First Posted Date
2005-09-14
Last Posted Date
2006-10-09
Lead Sponsor
Eisai Limited
Target Recruit Count
40
Registration Number
NCT00165867
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Cookridge Hospital, Leeds, United Kingdom

๐Ÿ‡ฌ๐Ÿ‡ง

Aberdeen Royal Infirmary, Aberdeen, United Kingdom

๐Ÿ‡ซ๐Ÿ‡ท

Hรดpitaux Civils de Colmar, Colmar, France

and more 4 locations

An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine

Phase 2
Terminated
Conditions
First Posted Date
2005-09-14
Last Posted Date
2014-07-01
Lead Sponsor
Eisai Limited
Target Recruit Count
62
Registration Number
NCT00165880
Locations
๐Ÿ‡ท๐Ÿ‡บ

Leningrad Regional Oncology Center, Kuzmolovo, Russian Federation

๐Ÿ‡ช๐Ÿ‡ธ

Hospital Unicersaitario de La Princesa, Madrid, Spain

๐Ÿ‡ฉ๐Ÿ‡ช

Stadt Kliniken Frankfurt-Hochst, Frankfurt, Germany

and more 29 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath